Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study
| Autor: | F. Cambien, Pierre-Yves Scarabin, A. E. Evans, L. Bara, Sylvain Ricard, D. Arveiler, Jean-Pierre Cambou, M M Samama, Odette Poirier, G. Luc |
|---|---|
| Rok vydání: | 1993 |
| Předmět: |
Adult
Male medicine.medical_specialty Genotype Molecular Sequence Data Myocardial Infarction Fibrinogen HaeIII Risk Factors Internal medicine Blood plasma Humans Medicine Myocardial infarction Allele Base Sequence business.industry Case-control study Genetic Variation Middle Aged medicine.disease Endocrinology Case-Control Studies Restriction fragment length polymorphism Cardiology and Cardiovascular Medicine business medicine.drug |
| Zdroj: | Arteriosclerosis and Thrombosis: A Journal of Vascular Biology. 13:886-891 |
| ISSN: | 1049-8834 |
| DOI: | 10.1161/01.atv.13.6.886 |
| Popis: | Increased plasma fibrinogen concentration is a major cardiovascular risk factor. Conflicting results on genetic variations in plasma fibrinogen levels have been reported. Furthermore, whether fibrinogen genotype is associated with the risk of ischemic heart disease has not been studied so far. An HaeIII restriction fragment length polymorphism of the beta-fibrinogen gene was used in a case-control study to investigate the genetic variation at this locus in relation to plasma fibrinogen concentrations and the risk of myocardial infarction (MI). Five hundred thirty-three male patients aged 27-66 years and 648 control subjects were recruited from four World Health Organization MONICA centers in Northern Ireland and in France. The absence of the HaeIII cutting site (H2 allele) was associated with a significant rise in fibrinogen concentrations in both patients and control subjects. The effect of the HaeIII polymorphism on plasma fibrinogen levels did not significantly differ between centers. Fibrinogen levels were higher in smokers than in nonsmokers. The difference between the two groups was larger in subjects with the genotype H2H2 than in those with either genotype H1H1 or H1H2, regardless of the case-control status. However, there was no significant interaction between smoking status and genotype in their effects on variance in fibrinogen levels, whereas fibrinogen levels. HaeIII genotype accounted for approximately 1% of the total variance in fibrinogen levels, whereas smoking and age together explained 7% and 5% in control subjects and patients, respectively. The frequency of the H2 allele was 0.21 in control subjects and 0.19 in patients.(ABSTRACT TRUNCATED AT 250 WORDS) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|